Searched for
CIPLA PHARMA LANKA
Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...- Healthcare stocks: Better to own a collection? 16 stocks from different segments with upside potential of 10 to 35% in 1 yearBefore you read on, be clear about one thing. The stocks on our list today are expensive in terms of valuations and may well witness correc...
- Suited for the long term, even with headwinds: 8 stocks from healthcare & pharma sectors with upside potential of up to 39%How to define a “defensive sector”? One where earnings increase in a secular manner and stocks have lower probability of witnessing a sharp...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Deven Choksey on what he likes about Adani Ports, Torrent Pharma nowDeven Choksey discusses the positive trajectory of Adani Ports, Torrent Pharma's strategic growth approach, and Tata Consumer's market read...
- Stock market update: Sugar stocks surge; Avadh Sugar zooms 6%Avadh Sugar, Dalmia Bharat Sugar and Magadh Sugar were the top gainers.
- Cipla gains as arm to buy 40% stake in Cipla Pharma LankaThe stock moved 1.81 per cent higher to trade at Rs 476.50 on the NSE.
- Stocks in the news: ZEEL, CDSL, SBI, Granules India, Cipla and DHFLBSE will offload 4 per cent stake in CDSL via an offer for sale (OFS).
- Samurai sunrise: Japanese bank MUFG is the new go-to financier for who's who of India IncFor once, India's favourite bankroller is not a Wall Street bank, nor a Swiss or a blueblooded British one.
- As a contra play, huge value in select pharma stocks: Sanjiv Bhasin, India Infoline“The headwind of rupee has become a tailwind for the pharma companies.”
- Ion Exchange betting big on water infra projectsAs part of its larger vision of environment management, Ion Exchange will also soon enter into solid waste to energy projects in India.
- ET Women Ahead: Corporate India's fastest rising women leadersThe stars of ET Woman Ahead say believe in yourself, leverage your strengths, and never try to act like a man.
- Meet India’s next generation of women leaders in pharmaThey are not afraid of taking business risks or foraying into newer businesses and have created environment and pushed for HR reforms targe...
- Sensex pares gains, Nifty tests 8,000; OMCs surge up to 7%The S&P BSE Sensex surged over 450 points in trade on Friday tracking positive trend seen in other Asian markets.
- Cipla only Indian firm in race for Kremers UrbanIf Cipla is able to close it, the deal, pegged at around $1.3 billion, will eclipse Lupin’s recent $880 million buyout of Gavis Pharma.
- Star bankers moving to newer roles, beefing up their teams by poaching from rivalsAs India’s economic prospects brighten, the investment banking community senses a revival in mergers and acquisitions activity.
- Cipla acquires 60% stake in Sri Lankan firm; stock up nearly 3%As part of its global expansion, Cipla has been active in acquisitions. Last year, it completed the buyout of South African pharma firm, sa...
- Cipla buys 60% stake in Sri Lankan co for $14 million"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regula...
- Arvind Remedies to invest Rs 190 crore in drug manufacturing unit"We are investing Rs 190 cr in our Chennai facility to make oral solids, dry powders and multi-dosage forms along with a couple of patented...
- Not right time to get out of TCS, Infosys: P Phani Sekhar, Angel BrokingAn investor does not lose much by holding on to these stocks or buying them on deeper declines from here, Phani Sekhar of Angel Broking say...
Load More
